Tsvaga kuti immunotherapy inogona sei kuva shamwari yako yechokwadi mukurova myeloma! Yedu blog inopa nzwisiso yakapusa musimba re immunotherapy kune akawanda myeloma. Usarasikirwa nechishandiso ichi chehondo ine simba, ine ruzivo rwakanyanya kurwisa myeloma. Ndiyo kiyi yako yekunzwisisa uye kutarisana nehondo nechivimbo netariro.
Kugamuchirwa kuongororo yakazara ye "Immunotherapy yeMultiple Myeloma” - iyo inoshanda sechombo chinoshamisa chekurwisa gomarara.
Multiple myeloma, rudzi rwegomarara reropa rinobva mumaseru eplasma, rinopa matambudziko akasiyana munzira dzechinyakare dzekurapa.
Iyi blog iri pano kuti ikubatsire kunzwisisa zvakawanda pamusoro peizvi gomarara reropa uye kukuzivisa iwe kurapwa kutsva uye kunovimbisa kunonzi immunotherapy.
Tichatanga nekutsanangura kuti myeloma yakawanda chii, inobata sei vanhu, uye kuti yakafambira mberi sei akawanda myeloma kurapwa muIndia iri kuita mutsauko mukuru mukurwisa kwatinoita kurwisa gomarara.
Immunotherapy mushonga wemagamba, uye nhasi tichatarisa kuti inoshanda sei uye tinzwe nyaya yevanhu vakabatsirwa nayo.
Saka huya nesu apo isu tichiongorora nyika yeakawanda myeloma uye kuona kuti immunotherapy iri kupa sei tariro uye kuunza shanduko dzakanaka pamabatiro atinoita mamiriro ezvinhu akaoma aya.
Mukati meNyika Yekenza Yeropa: Chii Chinonzi Multiple Myeloma?
Multiple myeloma imhando yegomarara rinotanga muropa rako. Kunoitika apo mamwe masero anokosha anozivikanwa semasero eplasma anokundikana kushanda zvakanaka.
Kazhinji, masero eplasma anobatsira muviri wako kurwisa utachiona nekugadzira masoja ekudzivirira chirwere. Asi mune akawanda myeloma, aya maseru anonetsa anovaka mumapfupa ako uye anokonzera matambudziko.
Aya masero anokuvadza anotora nzvimbo mumwongo webhonzo, unova mukati memapfupa ako akapfava umo masero eropa anogadzirwa.
Dzinosundira kure masero akanaka, uye panzvimbo pokubudisa masoja anobatsira, dzinobudisa mapuroteni asingashande zvakanaka. Izvi zvinokonzera myeloma yakawanda uye inoita kuti usanzwe zvakanaka.
Multiple Myeloma Inobata Sei Hupenyu Hwako?
Multiple myeloma inogona kukanganisa zvakanyanya hutano hwako munzira dzakasiyana siyana. Heino mhedziso yekuti cancer iyi inogona kukukanganisa sei:
Bone Pain uye Kutsemuka
Weaked Immune System
Kuneta
Anemia
Zvinetso zveKidney
Nervous System Matambudziko
Kukanganisa Utano Hwepfungwa
Chii chinonzi Immunotherapy?
Immunotherapy mushonga wegomarara unoshamisa unoshandisa immune system yemuviri kutsvaga nekuparadza maseru egomarara. Masoja ekudzivirira emuviri ako anokwanisa kuona nekubvisa anopinda akaita segomarara.
Immunotherapy ye myeloma inoshanda senge booster pfuti, ichiwedzera kugona kwe immune system kuona nekuparadza myeloma cell. Mhando iyi yekurapa cancer yakaratidza kushanda kwakakosha, ichivimbisa hupenyu hurefu kune vazhinji varwere vegomarara.
Uyezve, kufambira mberi kwazvino mukutsvagisa kwekurapa kunoramba kuchiunza mishonga mitsva ye immunotherapy senge - mota T cell therapy kurapwa muIndia.
Muchidimbu, immunotherapy yakafanana nekusimudzira kuzvidzivirira kwako kwechisikigo, kubatsira muviri wako kurwisa zvirwere zvakakomba nenzira yakangwara uye ine simba.
Ndedzipi Mhando dzeImmunotherapy yeMultiple Myeloma?
CAR-T Cell Therapy:
CAR T-cell therapy ndeyemunhu yakasarudzika myeloma immunotherapy kurapa iyo inosanganisira kubvisa masero eT emurwere (rudzi rwesero rekudzivirira), achiashandura murabhoritari kuratidza chimeric antigen receptor t cell inonangana nekenza maseru, wozoadzosera zvakare. kudzokera kumurwere.
Nhau dzakanaka ndedzekuti mutengo weCAR T Cell kurapwa muIndia ishoma kana ichienzaniswa nedzimwe nyika pasi rose. Sarudzo mbiri dzemota t cell immunotherapy yeakawanda myeloma dzakatobvumidzwa neFDA.
Immunomodulatory Agents:
Aya akawanda myeloma immunotherapy zvinodhaka chikamu chakakosha cheyakawanda myeloma kurapwa, uye inoshanda nekugadzirisa maitiro ekudzivirira kwemuviri.
Mishonga iyi haingonangi maseru egomarara chete asiwo inokanganisa nharaunda yakatenderedza kuita kuti isave nemutsa mukukura kwemasero emyeloma.
Mishonga iyi inobatsira kudzikisira kufambira mberi kwemultiple myeloma uye kuvandudza mhedzisiro yekurapa kwese nekupesvedzera mhinduro yemuviri.
Kana myeloma yemunhu ikadzoka kana kusaita zvakanaka kune mamwe marapirwo, mishonga iyi inogona kuramba ichibatsira.
Checkpoint Inhibitors:
Checkpoint inhibitors imhando ye immunotherapy inoshanda nekuvhara mamwe mapuroteni ari pamusoro pemasero ekudzivirira kana cancer maseru. Checkpoint inhibitors inoshanda seye immune system traffic controllers.
Ivo vanogona kuvharira masaini anononoka kudzika kwe immune system yedu kana kumisa masaini anosimbisa.
Izvi zvinobvumira miviri yedu kuti inange zvirinani uye kurwisa akawanda myeloma maseru ichidzivirira masero ane hutano. Masayendisiti ari kuyedza ma inhibitors aya mune immunotherapy miedzo yeakawanda myeloma, uye mhedzisiro yekutanga inoratidza vane vimbiso yakawanda.
Monoclonal Antibodies:
Monoclonal antibodies mamorekuru akagadzirwa murabhoritari anodzokorora kugona kwe immune system kurwisa mavhairasi anokuvadza uye mabhakitiriya. Masayendisiti akawana maitiro ekugadzira masoja ekudzivirira murabhoritari.
Aya masoja ekudzivirira chirwere akagadzirwa neLab anogona kuvandudza dziviriro yedu yechisikigo, achivabvumira kunanga uye kurwisa masero emyeloma. Uku kurapwa kwemultiple myeloma kunobatsira mukudzikisa huwandu hwemasero ane gomarara uye kudzora kufambira mberi kwechirwere.
Immunotherapy's Positive Impact paHupenyu
Immunotherapy mu myeloma iri kuunza tariro itsva muhupenyu hwevarwere vazhinji. Ngationei mamwe mabhenefiti ayo makuru -
Immunotherapy inogona kuvandudza kugona kwemuviri kuona uye kuparadza maseru ane kenza, kuvandudza kushanda kwekurapa.
Immunotherapy inowanzo konzera kushomeka kwemhedzisiro kana ichienzaniswa neakajairika marapirwo senge chemotherapy.
Ne immunotherapy, vamwe varwere vane kuregererwa kwenguva refu kana kupora kuzere, zvichipa tariro yehupenyu hurefu uye hutano.
Immunotherapy inovandudza hutano hwese hwemurwere wegomarara uye hupenyu hwehupenyu nekudzikisa kuoma kwemhedzisiro.
Sei Immunotherapy Yakanyorazve Iyo Hupenyu Hupenyu hweAkapona Kenza?
Bjørn Simonsen, makumi matanhatu nenomwe, akatarisana nerwendo rwakaoma aine akawanda myeloma. Kutevera kutenderera kwekutanga kwechemotherapy, kudzokazve muna 67 kwakakonzera marapirwo asina kubudirira.
Akaenda kuchipatara cheLu Daopei muna Kukadzi 2022 kuti agamuchire CART cell therapy. Kutevera kugadzirira nefludarabine uye cyclophosphamide, masero eCART akaiswa jekiseni.
Kunyange zvazvo akanga aine fivha yeneutropenia, sikarudzi yake yokurudyi yakadzokera kune yakajairika zvishoma nezvishoma. Pakazosvika zuva rechi28, bvunzo dzemwongo wemapfupa dzakaratidza hapana masero eplasma anooneka.
VaSimensen vakasunungurwa nekugadzwa kwekutevera kwakarongwa, uye ruzivo rwake runoratidza kuti CART cell treatment inogona kushandiswa sei kurapa varwere vane kudzokazve uye refractory multiple myeloma.
Iyi yakawanda myeloma immunotherapy yebudiriro nyaya inotidzidzisa kukosha kwekutsunga kwakasimba, kufunga kwakanaka, uye simba rekufambira mberi kwekurapa cancer.
Final Thoughts
Sezvaunotarisana nedenho yemyeloma, yeuka izvi: Wakafanana nemusoja akashinga muhondo youpenyu. Kunyangwe kana zvinhu zvikaita sekunge zvakaoma, iyo nzira nyowani ye immunotherapy yeyakawanda myeloma iri pano kubatsira.
Ndiyo nzira chaiyo murwendo rwako kurwisa cancer kupona. Saka, ramba uchienda, uye rega kurapwa uku kukutungamirire kune hutano uye hupenyu hunofadza.
Kana uine chero mibvunzo maererano nekurapwa uku, sunungukai kutifonera chero nguva. Isu tinogona kukubatanidza iwe neyakanakisa cancer Institute inopa yakanyanya yepamusoro immunotherapy kurapwa.
